ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

China suspends major platform that doubted Beijing COVID policies

Dingxiang Yuan posted articles debunking use of traditional medicine for virus

Now-suspended DXY, backed by tech giant Tencent, has at least 30 million followers on China's three major social apps.

HONG KONG -- China has suspended a health platform followed by tens of millions that debunked COVID-19 misinformation and criticized the government's boosting of traditional medicine as a treatment for the respiratory illness.

Regulators blocked platform Dingxiang Yuan's (DXY) ability to post articles to accounts on popular social media apps including Twitter-like Weibo, WeChat and TikTok's Chinese equivalent Douyin from this week, a source briefed on the matter told Nikkei Asia. The accounts will not be unfrozen without official approval, the source added.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more